WIN: a Feasibility Study of a Weight-Neutral Health Intervention
WIN
2 other identifiers
interventional
56
1 country
1
Brief Summary
The WIN intervention aims to improve the mental, social and physical health as well as quality of life of participants with BMI≥30 without focusing on their weight, and with no aim of weight loss. The WIN 6 months intervention is based on the principles and methods of the weight neutral movement Health at Every Size (HAES). The content is developed in a co-design process that involved Danish participants who have lived or professional experiences with such approaches. The intervention uses the method of intuitive eating to align eating behaviours with internal cues of hunger and fullness rather than rules, restrictions and external cues. The intervention also draws on components from Acceptance and Commitment Therapy (ACT) to manage body image concerns and weight stigma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedStudy Start
First participant enrolled
August 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 4, 2025
November 1, 2025
1.4 years
April 3, 2025
November 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary feasibility outcome: completion of follow-up
The proportion of participants who complete the follow-up examination, defined as answering the 'Mental health component' of the 36-item Short Form survey
24 weeks after inclusion
Secondary Outcomes (3)
Secondary feasibility outcome: recruitment proportion
Inclusion
Secondary feasibility outcome: fidelity midway
After group session 5 (study week 12)
Secondary feasibility outcome: fidelity end of intervention
After group session 11 (study week 23)
Other Outcomes (39)
Exploratory feasibility outcomes: Completion of follow-up, individual questionnaires
End of study (week 24)
Exploratory feasibility outcomes: Completion of follow-up, blood samples
End of study (week 24)
Exploratory feasibility outcomes: Completion of follow-up, hair samples
End of study (week 24)
- +36 more other outcomes
Study Arms (1)
WIN
EXPERIMENTALWeight-neutral health intervention
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥18 years old at screening.
- BMI ≥30 kg/m2.
- Residence in the Capital Region of Denmark.
- Able to understand and communicate in Danish.
- Informed consent.
You may not qualify if:
- Intends to become pregnant during the intervention or is currently pregnant.
- Has used weight loss medications or GLP-1 agonist treatment within the past 6 months or intends to use weight loss medications or begin any other intensive weight loss treatment during the WIN intervention.
- Has severe psychiatric or physical conditions that may interfere with participation or may present a safety concern.
- Cannot transport themselves to the group sessions.
- Is deemed unable to complete a two-hour group session, as assessed by the investigator at the clinical screening interview.
- Takes part in other research involving weight loss treatment that would compromise participation in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carsten Dirksenlead
- University of Copenhagencollaborator
- Copenhagen Trial Unit, Center for Clinical Intervention Researchcollaborator
Study Sites (1)
Research Unit for General Practice and Section of General Medicine, Department of Public Health, University of Copenhagen
Copenhagen, Denmark
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Carsten Dirksen, Ass. Professor
Hvidovre University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 3, 2025
First Posted
April 10, 2025
Study Start
August 7, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- When the results have been published
- Access Criteria
- Researchers with a protocol for their planned study
After the results have been published, the aim is to make a depersonalised dataset publicly available on e.g. ClinicalTrials.gov and/or the European Union (EU) Zenodo database (https://zenodo.org/). The final choice will reflect which platform(s) that are compliant with current legislation at that time.